Pharmacoeconomic and clinical impact of pharmaceutical service in the intensive care unit: a systematic review

2024-9-13

Potential risk of non-arteritic anterior ischaemic optic neuropathy in semaglutide users: pharmacovigilance insights

2024-9-6

Reimagining the ADR Alert Card: a novel approach to recurrence prevention in low-cost settings for adverse drug reactions

2024-9-3

Development of hospital clinical pharmacy services in Denmark from 2008 to 2023

2024-8-31

Costs, challenges and opportunities of decentralised chimeric antigen receptor T-cell production: a literature review and clinical experts’ interviews

2024-8-28

Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease

2024-8-24

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die

2024-8-22

Stability of intravenous medicines – evidence of maximum temperature reached in both summer and winter within soft shell elastomeric pumps

2024-8-22

Impact of the use of a drug–drug interaction checker on pharmacist interventions involving well-known strong interactors

2024-8-13

Pharmaceutical care in the screening process of phase I oncohaematological clinical trials

2024-8-13

Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrospective study in a French university hospital

2024-8-9

Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C

2024-7-31

Appropriate therapeutic drug monitoring of vancomycin improves outcomes of patients with bacterial infection in ICU

2024-7-30

Beyond conventional dosing: tailoring antimicrobial regimens for cachexia

2024-7-24

Cleaning validation for blister packaging machines in hospital-supplying pharmacies

2024-7-23

Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports

2024-7-22

Patient reported medication-related problems, adherence and waste of oral anticancer medication over time

2024-7-17

Pharmacotherapy of carbamazepine-treated patient after bariatric surgery: a complex interplay between altered absorption and drug–drug interactions

2024-7-17

Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug management

2024-7-15

How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?

2024-7-13

Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis

2024-7-4

Clopidogrel-induced thrombotic microangiopathy: a case report

2024-7-4

Taking care of caregivers: enhancing proper medication management for palliative care children with polypharmacy

2024-7-3

Antifungal prophylaxis against invasive<i>Candida</i>and<i>Aspergillus</i>infection in adult heart transplant recipients: protocol for a systematic review and meta-analysis

2024-7-2

Comment on: Retrospective study of patient characteristics and treatment for mucormycosis in post-COVID-19 population

2024-6-29

A single harmonised pharmacy process to improve clinical trial set-up times

2024-6-27

Potential medicine waste in the process of outpatients receiving cost-free medicines from medicine pick-up lockers in the North Denmark region

2024-6-26

Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients

2024-6-19

Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK

2024-6-14

Clinical and economic benefits of expanded access programs: should we strengthen these pharmacist-led initiatives?

2024-6-13

Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital

2024-6-13

HMGCR-associated myopathy in polymorbid patients with polypharmacy should not be attributed solely to statins

2024-6-12

Physical compatibility of ceftriaxone and cefepime in 0.45% sodium chloride, Ringer’s lactate solution, and Plasma-Lyte A

2024-6-11

Selection of initiatives to improve the management of patients with hereditary angioedema by the hospital pharmacy using the nominal group technique

2024-6-6

Inpatient case characteristics of SGLT2 inhibitor-associated diabetic ketoacidosis: a retrospective study

2024-6-6

Exploring susceptibility factors to medication dispensing errors through a retrospective study of patient-reported dispensing errors over 11 years: are dispensing errors indeed due to personal reasons for pharmacists?

2024-6-5

Evaluation of the appropriateness of vancomycin therapeutic drug monitoring in the intensive care unit with a clinical pharmacy approach, a cross-sectional study

2024-6-4

Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey

2024-6-4

European Association of Hospital Pharmacists (EAHP) guidance on the pharmacy handling of in vivo gene therapy medicinal products

2024-5-31

Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology

2024-5-31

Stability of clozapine tablets repackaged in dose administration aids using repackaging machines

2024-5-30

Patient safety culture and medication safety in European intensive care units: a focus group study

2024-5-29

Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy

2024-5-27

Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations

2024-5-24

Optimising adalimumab administration to improve patient experience and treatment adherence in immune-mediated inflammatory diseases

2024-5-24

Contribution of hospital pharmacists to sustainable healthcare: a systematic review

2024-5-22

Sedation modality in acute respiratory distress syndrome: does method of sedation affect length of stay, outcomes, or adverse events? A systematic review

2024-5-20

An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalation

2024-5-15

Empowering European hospital pharmacists in the face of heart failure

2024-5-13

Losartan potassium liquid formulation for paediatric hospital use: development and stability evaluation

2024-5-9